These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16247788)

  • 1. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
    Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
    Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functioning in breast cancer survivors: a controlled comparison.
    Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
    Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.
    Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB
    Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
    Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
    Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.
    van Dam FS; Schagen SB; Muller MJ; Boogerd W; vd Wall E; Droogleever Fortuyn ME; Rodenhuis S
    J Natl Cancer Inst; 1998 Feb; 90(3):210-8. PubMed ID: 9462678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer.
    Noal S; Levy C; Hardouin A; Rieux C; Heutte N; Ségura C; Collet F; Allouache D; Switsers O; Delcambre C; Delozier T; Henry-Amar M; Joly F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):795-803. PubMed ID: 20888704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight.
    Biglia N; Moggio G; Peano E; Sgandurra P; Ponzone R; Nappi RE; Sismondi P
    J Sex Med; 2010 May; 7(5):1891-900. PubMed ID: 20233281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-behavioral management of chemotherapy-related cognitive change.
    Ferguson RJ; Ahles TA; Saykin AJ; McDonald BC; Furstenberg CT; Cole BF; Mott LA
    Psychooncology; 2007 Aug; 16(8):772-7. PubMed ID: 17152119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
    Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL
    Menopause; 2007; 14(6):995-8. PubMed ID: 17898668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.